Exploring the Differences in Molecular Mechanisms and Key Biomarkers Between Membranous Nephropathy and Lupus...

Area of Science:

• Nephrology
• Immunology
• Genomics

Background:

• Membranous nephropathy (MN) and lupus nephritis (LN) are autoimmune kidney diseases with overlapping pathogenesis.
• Understanding the molecular distinctions between MN and LN is crucial for accurate diagnosis and treatment.
• Current knowledge on the interrelationship and specific molecular mechanisms differentiating MN and LN remains incomplete.

Purpose of the Study:

• To investigate the differences in molecular mechanisms between MN and LN.
• To identify key differentially expressed genes (DEGs) and potential biomarkers distinguishing MN from LN.
• To provide insights for developing more accurate animal models of MN.

Main Methods:

• Downloaded gene expression profiles from the GEO database (GSE99325, GSE99339, GSE104948, GSE104954).
• Identified differentially expressed genes (DEGs) in MN and LN kidney samples.
• Utilized Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, protein-protein interaction (PPI) network construction (Metascape), DEG filtering (NetworkAnalyst), and receiver operating characteristic (ROC) analysis.

Main Results:

• Identified 14 up-regulated and 77 down-regulated DEGs in MN glomeruli compared to LN.
• Found 21 down-regulated DEGs in MN renal tubules compared to LN, with no up-regulated genes.
• Screened six key genes (IFI6, MX1, XAF1, HERC6, IFI44L, IFI44) and observed significantly higher NELL1 expression in MN glomeruli versus LN.

Conclusions:

• The study highlights significant differences in gene expression profiles between MN and LN.
• Identified potential key biomarkers that may aid in differentiating these autoimmune kidney diseases.
• Findings offer novel insights into the pathogenesis of MN and LN, supporting the development of improved MN animal models.